Effects of glucocorticoid agonist and antagonist on the pathogenesis of L-arginine-induced acute pancreatitis in rat

Pancreas

Volumn 36, Issue 4, 2008, Pages 369-376

  Paszt, Attila ^a   Éder, Katalin ^b   Szabolcs, Annamária ^b   Tiszlavicz, László ^b   Lázár, György ^b   Duda, Ernö ^b   Takács, Tamás ^b   Lázár Jr , György ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Experimental pancreatitis; Glucocorticoid hormones; MIF; NF B; Organ failure

Indexed keywords

ARGININE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; METHYLPREDNISOLONE; MIFEPRISTONE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATION; LIVER INJURY; LIVER PROTECTION; LUNG INJURY; MALE; NONHUMAN; ORGAN WEIGHT; PANCREAS INJURY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME;

ACUTE DISEASE; AMYLASES; ANIMALS; ARGININE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; INFLAMMATION; INTERLEUKIN-6; L CELLS (CELL LINE); MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; METHYLPREDNISOLONE; MICE; MIFEPRISTONE; PANCREATITIS; RATS; RATS, WISTAR;

EID: 42549152796     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31815bd26a     Document Type: Article

References (46)

1. Stephenson HE Jr, Pfeffer RB, Saypol GM. Acute hemorrhagic pancreatitis. Report of a case with cortisone treatment. Arch Surg. 1952;65:307-308.
2. Gloor B, Reber HA. Effects of cytokines and other inflammatory mediators on human acute pancreatitis. J Intensive Care Med. 1998;13:305-312.
3. Osman MO, Jensen SL. Acute pancreatitis: the pathophysiological role of cytokines and integrins. Dig Surg. 1999;16:347-362.
4. Norman JG. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion. 1999;60:57-60.
5. Norman JG, Fink GW, Denham W, et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci. 1997;42:1783-1788.
6. Reishi A, Tooru S, Kenji K, et al. The role of endogenous glucocorticoids in rat experimental models of acute pancreatitis. Gastroenterology. 1995;109:933-943.
7. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351-1362.
8. Elenkov IJ, Kovacs K, Duda E, et al. Presynaptic inhibitory effect of TNF-alpha on the release of noradrenaline in isolated median eminence. J Neuroimmunol. 1992;41(1):117-120.
9. Goldstein RA, Dowen DL, Fauci AS. Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. 2nd ed. New York: Raven Press; 1992: 1061-1081.
10. Orth DN, Kovacs WJ, DeBold CR. The adrenal cortex. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. 8th ed. Philadelphia: WB Saunders; 1992:489-619.
11. Zuckerman SH, Shellhaas J, Butler LD. Differential regulation of lipopolysaccharide-induced interleukin-1 and tumour necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol. 1989;19:301-305.
12. Muller CA, Vogeser M, Belyaev O, et al. Role of endogenous glucocorticoid metabolism in human acute pancreatitis. Crit Care Med. 2006;34(4):1060-1066.
13. Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced counter-regulator of cytokine production. Nature. 1995;377:68-71.
14. Bucala R. Neuroimmunomodulation by macrophage migration inhibitory factor (MIF). Ann NY Acad Sci. 1998;840:74-82.
15. Van Rooijen N, Van Nieuwmegen R. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res. 1984;238:355-358.
16. Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of amylase activities in human serum and urine. Clin Chim Acta. 1969;26:437-444.
17. Aarben LA, De Groot ER, Schaap OL, et al. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987;17:1411-1416.
18. Christopher BH, Hani P, Grewal L, et al. Anti-TNF-α therapy improves survival and ameliorates the pathophysiologic sequale in acute pancreatitis in the rat. Am J Surg. 1996;71:274-280.
19. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153:80-82.
20. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966;56:72-77.
21. Beutler B, Krochin N, Milsark IW, et al. Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science. 1986;232:977-980.
22. Scheinman RI, Cogswell PC, Lofquist AK, et al. Role of transcriptional activation of IκBα in mediation of immunosuppression of glucocorticoids. Science. 1995;270:283-286.
23. Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science. 1995;270:286-290
24. Fingerle-Rowson G, Koch P, Bikoff R, et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol. 2003;162:47-56.
25. Lue H, Kleemann R, Calandra T, et al. Macrophage migration inhibitory factor (MIF): mechanism of action and role in disease. Microbes Infect. 2002;4:449-460.
26. Bucala R. MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J. 1996;10:1607-1613.
27. Tierney T, Patel R, Stead CA, et al. Macrophage migration inhibitory factor is released from pituitary folliculostellate-like cells by endotoxin and dexamethasone and attenuates the steroid-induced inhibition of interleukin 6 release. Endocrinology. 2005;146:35-43.
28. Rahman SH, Menon KV, Holmfield JH, et al. Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis. Ann Surg. 2007;245:282-289.
29. Nagasaki K, Matsumoto K, Kaneda M, et al. Effects of preinjury administration of corticosteroids on pseudointimal hyperplasia and cytokine response in a rat model of balloon aortic injury. World J Surg. 2004;28:910-916.
30. Bruhn A, Verdant C, Vercruysse V, et al. Effects of dexamethasone on macrophage migration inhibitory factor production in sepsis. Shock. 2006;26:169-173.
31. Maxime V, Fitting C, Annane D, et al. Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. J Infect Dis. 2005;191:138-144.
32. Cao WG, Morin M, Sengers V, et al. Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappa β. Hum Reprod. 2006;21:421-428.
33. Shimizu T, Nishihira J, Watanabe H, et al. Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells. J Biol Chem. 2004;279:13729-1337.
34. Vaquero E, Gukovsky I, Zaninovic V, et al. Localized pancreatic NF-κB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol. 2001;280:1197-1208.
35. Adcock IM, Shirasaki H, Gelder CM, et al. The effect of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci. 1994;55:1147-1153.
36. Scheinman RI, Gualbert A, Jewell CM, et al. Characterization of mechanism involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol. 1995;15:943-953.
37. Barnes PJ, Karin M. Mechanism of disease: nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;15:1066-1071.
38. Daun JM, Cannon JG. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα. Am J Physiol Regul Integr Comp Physiol. 2000;279:1043-1049.
39. Pescador R, Manso MA, Rebollo AJ, et al. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein. Pancreas. 1995;11:165-172.
40. De Dios I, San Roman JI, Manso M, et al. Glucocorticoid effects on exocrine pancreatic secretion in cerulein-induced acute pancreatitis in the rat. Arch Int Physiol Biochim. 1990;98:361-369.
41. Gloor B, Uhl W, Tcholakov O, et al. Hydrocortisone treatment of early SIRS in acute experimental pancreatitis. Dig Dis Sci. 2001;46:2154-2161.
42. Paszt A, Takacs T, Rakonczay Z, et al. The role of the glucocorticoid-dependent mechanism in the progression of sodium taurocholate-induced acute pancreatitis in the rat. Pancreas. 2004;29:75-82.
43. Parant M, Le Contel C, Parant F, et al. Influence of endogenous glucocorticoid on endotoxin-induced production of circulating TNF-alpha. Lymphokine Cytokine Res. 1991;10:265-271.
44. Hawes AS, Rock GS, Keogh CV, et al. In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine response to Escherichia coli endotoxin. Infect Immun. 1992;60:2641-2647.
45. Fantuzzi G, Di Santo E, Sacco S, et al. Role of the hypothalamus- pituitary-adrenal axis in the regulation of TNF production in mice. J Immunol. 1995;155:3552-3555.
46. Lazar G Jr, Duda E, Lazar G. Effect of RU-38486 on TNF production and toxicity. FEBS Lett. 1992;308:137-140.